Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197041
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2005-09-13
Brief Title:
A Study to Evaluate the Safety Immunogenicity and Efficacy of GlaxoSmithKline GSK Biologicals Candidate Malaria Vaccine RTSSAS02A When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique
Sponsor:
Organization:
GlaxoSmithKline